Ausgabe 6/1997
Inhalt (7 Artikel)
Poly(ethylene glycol) modification of β-glucuronidase-antibody conjugates for solid-tumor therapy by targeted activation of glucuronide prodrugs
Tian-Lu Cheng, Bing-Mae Chen, Lai-Yee Chan, P.-Y. Wu, Ji-Wang Chern, S. R. Roffler
Interleukin-1α synergistic in vivo enhancement of cyclophosphamide- and carboplatin-mediated antitumor activity
Wei-Dong Yu, Ming-Jei Chang, Donald L. Trump, C. S. Johnson
Comparison of the biological properties of two anti-mucin-1 antibodies prepared for imaging and therapy
G. A. Pietersz, L. Wenjun, Kenia Krauer, Terry Baker, Daniel Wreschner, Ian F. C. McKenzie
Variable expression of tumor necrosis factor α in human malignant melanoma localized by in situ hybridization for mRNA
Cecilia Bergenwald, Gunilla Westermark, B. Sander
Quantitative analysis of cytokine mRNA expression in peripheral blood mononuclear cells following treatment with interleukin-2
Masashi Adachi, Hiroshi Inoue, Shinya Arinaga, Jian Li, Hiroaki Ueo, Masaki Mori, T. Akiyoshi
Tumor-peptide-pulsed dendritic cells isolated from spleen or cultured in vitro from bone marrow precursors can provide protection against tumor challenge
Ian F. Hermans, Angela Daish, Pisana Moroni-Rawson, F. Ronchese
A phase II study of interferon α and low-dose subcutaneous interleukin-2 in advanced renal cell carcinoma
A. Piga, Paolo Giordani, Agata Quattrone, Marco Giulioni, Giorgio De Signoribus, Stefania Antognoli, Riccardo Cellerino